CMRX

Chimerix, Inc. Press Releases

$38.26
*  
0.63
1.62%
Get CMRX Alerts
*Delayed - data as of Jan. 23, 2015  -  Find a broker to begin trading CMRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Chimerix Receives Notice of Allowance for Brincidofovir Composition of Matter Patent Extending Exclusivity to 2034
1/12/2015 8:30:00 AM - GlobeNewswire


Chimerix Provides Update on Brincidofovir Pivotal Phase 3 AdVise Trial for the Treatment of Adenovirus
1/8/2015 8:30:00 AM - GlobeNewswire


Biocept's Proprietary Oncology Diagnostics to be Offered on America's Choice Provider Network
1/7/2015 8:30:00 AM - GlobeNewswire


Chimerix to Present at the 33rd Annual J.P. Morgan Healthcare Conference
1/7/2015 8:30:00 AM - GlobeNewswire


Chimerix Provides Recap of 2014 Events
12/23/2014 8:30:00 AM - GlobeNewswire


Chimerix and ContraVir Pharmaceuticals Establish Strategic Collaboration for Antiviral Drug Candidate CMX157
12/18/2014 6:00:00 AM - GlobeNewswire


Chimerix Appoints Ronald C. Renaud, Jr. to Board of Directors
12/17/2014 4:30:00 PM - GlobeNewswire


Chimerix to Present at the Piper Jaffray Healthcare Conference
11/25/2014 8:00:00 AM - GlobeNewswire


Chimerix's Brincidofovir Selected for Use in Ebola Clinical Trial in West Africa by International Consortium
11/13/2014 12:30:00 PM - GlobeNewswire


Chimerix''s Brincidofovir Selected for Use in Ebola Clinical Trial in West Africa by International Consortium
11/13/2014 12:30:00 PM - GlobeNewswire


Chimerix to Present at the Stifel Healthcare Conference
11/11/2014 8:00:00 AM - GlobeNewswire


Chimerix Announces Third Quarter 2014 Financial Results
11/7/2014 7:00:00 AM - GlobeNewswire


Chimerix Announces Completion of Public Offering of Common Stock and Exercise in Full of Option to Purchase Additional Shares of Common Stock
11/5/2014 4:04:00 PM - GlobeNewswire


Chimerix Names Two New Executives: Peter Payne as Senior Vice President, Business Development and Corporate Strategy, and Roberto Guzman, JD, MBA, MCLFS, as Vice President, Corporate Compliance
11/3/2014 6:29:00 PM - GlobeNewswire


Chimerix to Announce Third Quarter Financial Results on November 7, 2014
10/31/2014 5:58:00 PM - GlobeNewswire


Chimerix Prices Public Offering of Common Stock
10/30/2014 6:37:00 PM - GlobeNewswire


Chimerix Announces Commencement of Public Offering of Common Stock
10/29/2014 4:55:00 PM - GlobeNewswire